< 1 minute read
Sep. 18, 2021
BAY 1214784 Completes Ph. I for Uterine Fibroids With Good Tolerability
BAY 1214784
oral hGnRH-R hormone receptor antagonist to treat of uterine fibroids, Ph. I completed from cell-based 2.5M cmpd HTS + opt. J. Med. Chem., Oct. 22, 2020 issue Bayer AG, Berlin, DE
Loading...
